Welcome to the Infant's Tylenol Class Action Settlement Website


Para una notificacion en Espanol, clic AQUÍ.

Your rights and options – and the deadlines to exercise them – are explained on this website.

A proposed settlement has been reached in a class action lawsuit about the packaging and advertising of Infants’ Tylenol. The plaintiffs in the lawsuit claim that the Infants’ Tylenol packaging (the text “Infants” and a picture of a mother holding her baby) deceives consumers into believing Infants’ Tylenol is unique/ specially formulated for infants, when the bottle contains liquid acetaminophen of the same concentration in Children’s Tylenol, and therefore causes consumers to overpay for Infants’ Tylenol.  Johnson & Johnson Consumer Inc. ("JJCI") denies all the plaintiffs’ allegations of deception and asserts that the safety features of Infants’ Tylenol, especially the accompanying syringe for safe dosing of very young children, means Infants’ and Children’s are different products. 

You are included in the Settlement as a “Class Member” if you are in the United States and purchased Infants’ Tylenol for personal or household use at any time from October 3, 2014 to January 6, 2020.

The following persons are excluded from the Settlement Class: (a) Defendants, (b) the officers, directors, or employees of Defendants and their immediate families, (c) any entity in which Defendants have a controlling interest, (d) any affiliate, legal representative, heir, or assign of Defendants, (e) all federal court judges who have presided over this Action and their immediate families, (f) all persons who submit a valid request for exclusion from the Class, and (g) those who purchased Infants’ Tylenol for the purpose of resale or for use in a business setting.

JJCI will create a fund of up to $6.315 million. After deducting administrative costs, Class Counsel’s attorneys’ fees and expenses, and service awards for the named plaintiffs, the balance will be used to pay Class Member claims. Class Members may claim $2.15 for every 1 and 2 fl. oz. bottle of Infants’ Tylenol purchased. A maximum of 7 bottles or $15.05 may be claimed without proof of purchase. An unlimited number of bottles may be claimed with proof of purchase for all Infants’ Tylenol purchases.

In addition, JJCI will use reasonably diligent efforts to modify the packaging of Infants’ Tylenol and commit to educating and informing consumers, in response to inquiries and complaints to JJCI’s Consumer Care Center (CCC) relating to comparisons of Infant’s Tylenol and Children’s Tylenol, that the liquid medicine within the bottles of both Infants’ Tylenol and Children’s Tylenol contains the same concentration of liquid acetaminophen.

Case Relevant Event


You must submit a Claim Form by

April 13, 2020

Submit an Objection by

May 26, 2020

Ask to be Excluded by

April 13, 2020

Final Approval Hearing

June 22, 2020  at 8:30 a.m.